Anti-PTRH2 monoclonal antibody
Pre-made anti-PTRH2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to PTRH2/PTRH2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1461-Ab-1/ GM-Tg-hg-IP1461-Ab-2 | Anti-Human PTRH2 monoclonal antibody | Human |
GM-Tg-rg-IP1461-Ab-1/ GM-Tg-rg-IP1461-Ab-2 | Anti-Rat PTRH2 monoclonal antibody | Rat |
GM-Tg-mg-IP1461-Ab-1/ GM-Tg-mg-IP1461-Ab-2 | Anti-Mouse PTRH2 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1461-Ab-1/ GM-Tg-cynog-IP1461-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PTRH2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1461-Ab-1/ GM-Tg-felg-IP1461-Ab-2 | Anti-Feline PTRH2 monoclonal antibody | Feline |
GM-Tg-cang-IP1461-Ab-1/ GM-Tg-cang-IP1461-Ab-2 | Anti-Canine PTRH2 monoclonal antibody | Canine |
GM-Tg-bovg-IP1461-Ab-1/ GM-Tg-bovg-IP1461-Ab-2 | Anti-Bovine PTRH2 monoclonal antibody | Bovine |
GM-Tg-equg-IP1461-Ab-1/ GM-Tg-equg-IP1461-Ab-2 | Anti-Equine PTRH2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1461-Ab-1/ GM-Tg-hg-IP1461-Ab-2; GM-Tg-rg-IP1461-Ab-1/ GM-Tg-rg-IP1461-Ab-2; GM-Tg-mg-IP1461-Ab-1/ GM-Tg-mg-IP1461-Ab-2; GM-Tg-cynog-IP1461-Ab-1/ GM-Tg-cynog-IP1461-Ab-2; GM-Tg-felg-IP1461-Ab-1/ GM-Tg-felg-IP1461-Ab-2; GM-Tg-cang-IP1461-Ab-1/ GM-Tg-cang-IP1461-Ab-2; GM-Tg-bovg-IP1461-Ab-1/ GM-Tg-bovg-IP1461-Ab-2; GM-Tg-equg-IP1461-Ab-1/ GM-Tg-equg-IP1461-Ab-2 |
Products Name | Anti-PTRH2 monoclonal antibody |
Format | mab |
Target Name | PTRH2 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-PTRH2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1461-Ag-1 | Recombinant multi-species PTH2/ PTRH2/ BIT1 protein |
Target information
Target ID | GM-IP1461 |
Target Name | PTRH2 |
Gene ID | 51651,217057,287593,711736,100682594,101093219,516595,100071096 |
Gene Symbol and Synonyms | A230072I16Rik,BIT1,CFAP37,CGI-147,IMNEPD,PTH,PTH 2,PTH2,PTRH2,RGD1306819 |
Uniprot Accession | Q9Y3E5,Q3ZBL5 |
Uniprot Entry Name | PTH2_HUMAN,PTH2_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000141378 |
Target Classification | N/A |
The target: PTRH2, gene name: PTRH2, also named as BIT1, CFAP37, CGI-147, IMNEPD, PTH, PTH 2, PTH2. The protein encoded by this gene is a mitochondrial protein with two putative domains, an N-terminal mitochondrial localization sequence, and a UPF0099 domain. In vitro assays suggest that this protein possesses peptidyl-tRNA hydrolase activity, to release the peptidyl moiety from tRNA, thereby preventing the accumulation of dissociated peptidyl-tRNA that could reduce the efficiency of translation. This protein also plays a role regulating cell survival and death. It promotes survival as part of an integrin-signaling pathway for cells attached to the extracellular matrix (ECM), but also promotes apoptosis in cells that have lost their attachment to the ECM, a process called anoikos. After loss of cell attachment to the ECM, this protein is phosphorylated, is released from the mitochondria into the cytosol, and promotes caspase-independent apoptosis through interactions with transcriptional regulators. This gene has been implicated in the development and progression of tumors, and mutations in this gene have been associated with an infantile multisystem neurologic, endocrine, and pancreatic disease (INMEPD) characterized by intellectual disability, postnatal microcephaly, progressive cerebellar atrophy, hearing impairment, polyneuropathy, failure to thrive, and organ fibrosis with exocrine pancreas insufficiency (PMID: 25574476). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.